![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » REACTION BIOLOGY CORP. AWARDED NIH SBIR GRANT FOR KINASE RADIOISOTOPE MICROARRAY SCREENING DEVELOPMENT
REACTION BIOLOGY CORP. AWARDED NIH SBIR GRANT FOR KINASE RADIOISOTOPE MICROARRAY SCREENING DEVELOPMENT
June 20, 2006
Reaction Biology Corporation today announced that it has been awarded an SBIR grant from the National Cancer Institute to create a new kinase profiling and high throughput screening method using radioisotopes and microarrays. The $940,000 grant will be used to migrate the current well-plate radioisotope methods onto RBC's DiscoveryDot nanoliter screening platform. Send2Press (http://www.send2press.com/newswire/2006-06-0620-001.shtml)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct